1. Current Issues in Enzyme Therapy for Gaucher Disease

   • Gregory A. Grabowski

   Leading Article 13 October 2012 Pages: 159 - 167

2. Use of Viral Resistance Patterns to Antiretroviral Drugs in Optimising Selection of Drug Combinations and Sequences

   • G. J. Moyle

   Review Article 13 October 2012 Pages: 168 - 185

3. The Implications of Noncompliance with Antihypertensive Medication

   • Briegeen Girvin
   • G. D. Johnston

   Review Article 13 October 2012 Pages: 186 - 195

4. Recognition and Treatment of Unstable Angina

   • Claudio Brunelli
   • Paolo Spallarossa
   • Salvatore Caponnetto

   Disease Management 13 October 2012 Pages: 196 - 208

5. Treatment and Prophylaxis of Tinea Infections

   • Géerald E. Piérard
   • Jorge E. Arrese
   • Claudine Piérard-Franchimont

   Disease Management 13 October 2012 Pages: 209 - 224

6. Cidofovir

   • Andrew P. Lea
   • Harriet M. Bryson

   New Drug Profile 13 October 2012 Pages: 225 - 230

7. Cidofovir

   • Mark A. Jacobson

   New Drug Profile 13 October 2012 Pages: 231 - 231

8. Cidofovir

   • Michael A. Polis

   New Drug Profile 13 October 2012 Pages: 231 - 231

9. Nisoldipine Coat-Core

   • Greg L. Plosker
   • Diana Faulds

   Drug Evaluation 13 October 2012 Pages: 232 - 253

10. Erratum to Itraconazole: a review of its pharmacological properties and therapeutic use in the management of superficial fungal infections

    • M. Haria
    • H. M. Bryson
    • S. S. Patel

    Erratum 13 October 2012 Pages: 253 - 253

11. Acellular Pertussis Vaccine (Infanrix™-DTPa; SB-3)

    • Sanjay S. Patel
    • Antona J. Wagstaff

    Drug Evaluation 13 October 2012 Pages: 254 - 275

12. Dalteparin Sodium

    • Christopher J. Dunn
    • Eugene M. Sorkin

    Drug Evaluation 13 October 2012 Pages: 276 - 305